Updated June 08, 2015.
Cancer care is extremely costly, and ovarian cancer is right at the top of the list of most expensive cancers to take care of. The good news is that this is partly due to the fact that ovarian cancer patients live longer with the various drugs available for treatment. The bad news is that this can chew up a lot of money with co-pays, deductibles and lack of insurance coverage.
Here is a list of some information and assistance programs which may help.
Your local city and state government may have other programs available. You will be required to provide proof of income and qualifying for assistance is very strict and specific requirements must be met. Nonetheless, it is worth applying if you need help to get the treatment(s) you need.
Amgen Oncology Assistance 800-272-9376
Amgen produces several common drugs which are used during chemotherapy to help keep blood counts in the normal range. The two most often used in ovarian cancer treatment are Aranesp (darbepoetin alfa), and Neulasta (pegfilgrastim).
AstraZeneca 800-292-6363
General prescription drug assistance for low income patients with MediCare Part D coverage or those without insurance.
Bristol-Myers Squibb Patient Assistance Foundation 800-736-0003
A foundation which provides assistance to those who have no insurance and not qualified for help in any other government-run prescription assistance program.
CancerCare 800-813-4673
General financial assistance programs available.
Genentech 888-249-4918
Genentech produces several biological treatments which are used in ovarian cancer treatment.
The main two are Avastin (bevacizumab) and Herceptin (trastuzumab). This website offers advice regarding insurance reimbursement and links to foundation assistance programs.
GlaxoSmithKline 866-265-6491
Assistance to patients with low income and MediCare Part D or no prescription drug benefits. Among the drugs manufactured by GSK is Topotecan, which is used for treatment of recurrence.
GlaxoSmithKline GSK Access 866-475-3678
GSK has another program with similar assistance focus.
Lilly Cares 800-545-6962
Assistance program for patients who need Lilly products. Gemzar, a chemotherapy agent used for ovarian cancer recurrence treatment is manufactured by Lilly.
Merck 866-363-6379
Merck provides assistance to those with insurance to justify use of their medications as well as programs for those without insurance. They manufacture Emend, which is a medication used to prevent nausea and vomiting during chemotherapy.
Partnership for Prescription Assistance 888-477-2669
The Partnership for Prescription Assistance brings together America’s pharmaceutical companies, doctors, other health care providers, patient advocacy organizations and community groups to help qualifying patients who lack prescription coverage get the medicines they need through the public or private program that’s right for them. Many will get them free or nearly free.
Patient Advocate Foundation's Co-Pay Relief 866-512-3861
The Patient Advocate Foundation (PAF) Co-Pay Relief Program (CPR) currently provides direct financial support to insured patients, including Medicare Part D beneficiaries, who must financially and medically qualify to access pharmaceutical co-payment assistance. The program offers personal service to all patients through the use of call counselors; personally guiding patients through the enrollment process.
Pfizer 877-744-5675
Pfizer Helpful Answers offers patient assistance programs to people without prescription coverage. They have some up and coming biologicals which may help treat ovarian cancer.
Roche Patient Assistance Foundation 877-757-6243
Assistance program to help patients without insurance. Roche has some up and coming ovarian cancer treatments in research trials at this time, such as Epothilone R1645.
RxAssist Patient Assistance Programs RxAssist is a web directory which offers a comprehensive database of patient assistance programs, as well as practical tools, news, and articles so that health care professionals and patients can find the information they need. All in one place.
Rx Hope (732) 507-7400
RxHope directly manages and consults on patient assistance programs for pharmaceutical companies of all sizes.
Sanofi-Aventis’s PACT+ 800-996-6626
For reimbursement services or patient assistance on The PACT+ Program products including these drugs used in ovarian cancer: Taxotere® (docetaxel) and Eloxatin® (oxaliplatin injection) chemotherapy agents; Anzemet® (dolasetron mesylate) injection/tablets for nausea and vomiting.
Schering-Plough’s Commitment to Care Program 800-521-7157
Assistance program for low income patients. Schering-Plough manufactures CAELYX (pegylated liposomal doxorubicin HCI), which is similar to Doxil chemotherapy, used for treatment of recurrence.
Together Rx Access Card 800-444-4106
This is a free prescription-savings card for eligible residents of the United States and Puerto Rico who have no prescription drug coverage. It is a public service program created and sponsored by a group of some of the world’s largest pharmaceutical companies, providing up to 40% savings on medications.
Cancer care is extremely costly, and ovarian cancer is right at the top of the list of most expensive cancers to take care of. The good news is that this is partly due to the fact that ovarian cancer patients live longer with the various drugs available for treatment. The bad news is that this can chew up a lot of money with co-pays, deductibles and lack of insurance coverage.
Here is a list of some information and assistance programs which may help.
Your local city and state government may have other programs available. You will be required to provide proof of income and qualifying for assistance is very strict and specific requirements must be met. Nonetheless, it is worth applying if you need help to get the treatment(s) you need.
Amgen Oncology Assistance 800-272-9376
Amgen produces several common drugs which are used during chemotherapy to help keep blood counts in the normal range. The two most often used in ovarian cancer treatment are Aranesp (darbepoetin alfa), and Neulasta (pegfilgrastim).
AstraZeneca 800-292-6363
General prescription drug assistance for low income patients with MediCare Part D coverage or those without insurance.
Bristol-Myers Squibb Patient Assistance Foundation 800-736-0003
A foundation which provides assistance to those who have no insurance and not qualified for help in any other government-run prescription assistance program.
CancerCare 800-813-4673
General financial assistance programs available.
Genentech 888-249-4918
Genentech produces several biological treatments which are used in ovarian cancer treatment.
The main two are Avastin (bevacizumab) and Herceptin (trastuzumab). This website offers advice regarding insurance reimbursement and links to foundation assistance programs.
GlaxoSmithKline 866-265-6491
Assistance to patients with low income and MediCare Part D or no prescription drug benefits. Among the drugs manufactured by GSK is Topotecan, which is used for treatment of recurrence.
GlaxoSmithKline GSK Access 866-475-3678
GSK has another program with similar assistance focus.
Lilly Cares 800-545-6962
Assistance program for patients who need Lilly products. Gemzar, a chemotherapy agent used for ovarian cancer recurrence treatment is manufactured by Lilly.
Merck 866-363-6379
Merck provides assistance to those with insurance to justify use of their medications as well as programs for those without insurance. They manufacture Emend, which is a medication used to prevent nausea and vomiting during chemotherapy.
Partnership for Prescription Assistance 888-477-2669
The Partnership for Prescription Assistance brings together America’s pharmaceutical companies, doctors, other health care providers, patient advocacy organizations and community groups to help qualifying patients who lack prescription coverage get the medicines they need through the public or private program that’s right for them. Many will get them free or nearly free.
Patient Advocate Foundation's Co-Pay Relief 866-512-3861
The Patient Advocate Foundation (PAF) Co-Pay Relief Program (CPR) currently provides direct financial support to insured patients, including Medicare Part D beneficiaries, who must financially and medically qualify to access pharmaceutical co-payment assistance. The program offers personal service to all patients through the use of call counselors; personally guiding patients through the enrollment process.
Pfizer 877-744-5675
Pfizer Helpful Answers offers patient assistance programs to people without prescription coverage. They have some up and coming biologicals which may help treat ovarian cancer.
Roche Patient Assistance Foundation 877-757-6243
Assistance program to help patients without insurance. Roche has some up and coming ovarian cancer treatments in research trials at this time, such as Epothilone R1645.
RxAssist Patient Assistance Programs RxAssist is a web directory which offers a comprehensive database of patient assistance programs, as well as practical tools, news, and articles so that health care professionals and patients can find the information they need. All in one place.
Rx Hope (732) 507-7400
RxHope directly manages and consults on patient assistance programs for pharmaceutical companies of all sizes.
Sanofi-Aventis’s PACT+ 800-996-6626
For reimbursement services or patient assistance on The PACT+ Program products including these drugs used in ovarian cancer: Taxotere® (docetaxel) and Eloxatin® (oxaliplatin injection) chemotherapy agents; Anzemet® (dolasetron mesylate) injection/tablets for nausea and vomiting.
Schering-Plough’s Commitment to Care Program 800-521-7157
Assistance program for low income patients. Schering-Plough manufactures CAELYX (pegylated liposomal doxorubicin HCI), which is similar to Doxil chemotherapy, used for treatment of recurrence.
Together Rx Access Card 800-444-4106
This is a free prescription-savings card for eligible residents of the United States and Puerto Rico who have no prescription drug coverage. It is a public service program created and sponsored by a group of some of the world’s largest pharmaceutical companies, providing up to 40% savings on medications.